High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections

被引:57
作者
Jin, X
Demoitie, MA
Donahoe, SM
Ogg, GS
Bonhoeffer, S
Kakimoto, WM
Gillespie, G
Moss, PA
Dyer, W
Kurilla, MG
Riddell, SR
Downie, J
Sullivan, JS
McMichael, AJ
Workman, C
Nixon, DF
机构
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA
[2] Inst Mol Med, Human Immunol Unit, Oxford, England
[3] Friedrich Miescher Inst, Basel, Switzerland
[4] Australian Red Cross Blood Serv, Sydney, NSW, Australia
[5] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA
[6] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
关键词
D O I
10.1086/315201
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
How the cellular immune response copes with diverse antigenic competition is poorly understood. Responses of virus-specific cytotoxic T lymphocytes (CTL) were examined longitudinally in an individual coinfected with human immunodeficiency virus type 1 (HIV-1), Epstein-Barr virus (EBV), and cytomegalovirus (CMV), CTL responses to all 3 viruses were quantified by Limiting dilution analysis and staining with HLA-A*0201 tetrameric complexes folded with HIV-1, EBV, and CMV peptides, A predominance of CMV-pp65-specific CTL was found, with a much lower frequency of CTL to HIV-1 Gag and Pol and to EBV-BMLF1 and LMP2. The high frequency of CMV-specific CTL, compared with HIV-1- and EBV-specific CTL, was confirmed in an additional 16 HLA-A*0201-positive virus-coinfected subjects. Therefore, the human immune system can mount CTL responses to multiple viral antigens simultaneously, albeit with different strengths.
引用
收藏
页码:165 / 175
页数:11
相关论文
共 53 条
[21]   Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: Evidence supporting a protective role for CTL in vivo [J].
Greenough, TC ;
Brettler, DB ;
Somasundaran, M ;
Panicali, DL ;
Sullivan, JL .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (01) :118-125
[22]   QUANTITATION OF ANTIGEN-PRESENTING CELL MHC CLASS-II PEPTIDE COMPLEXES NECESSARY FOR T-CELL STIMULATION [J].
HARDING, CV ;
UNANUE, ER .
NATURE, 1990, 346 (6284) :574-576
[23]   SERIOUS CYTOMEGALO-VIRUS DISEASE IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) [J].
JACOBSON, MA ;
MILLS, J .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (04) :585-594
[24]   Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques [J].
Jin, X ;
Bauer, DE ;
Tuttleton, SE ;
Lewin, S ;
Gettie, A ;
Blanchard, J ;
Irwin, CE ;
Safrit, JT ;
Mittler, J ;
Weinberger, L ;
Kostrikis, LG ;
Zhang, LQ ;
Perelson, AS ;
Ho, DD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (06) :991-998
[25]   AN EPSTEIN-BARR VIRUS IMMEDIATE-EARLY GENE-PRODUCT TRANS-ACTIVATES GENE-EXPRESSION FROM THE HUMAN IMMUNODEFICIENCY VIRUS LONG TERMINAL REPEAT [J].
KENNEY, S ;
KAMINE, J ;
MARKOVITZ, D ;
FENRICK, R ;
PAGANO, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (05) :1652-1656
[26]   Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection - Different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma [J].
Kersten, MJ ;
Klein, MR ;
Holwerda, AM ;
Miedema, F ;
vanOers, MHJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1525-1533
[27]   KINETICS OF GAG-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES DURING THE CLINICAL COURSE OF HIV-1 INFECTION - A LONGITUDINAL ANALYSIS OF RAPID PROGRESSORS AND LONG-TERM ASYMPTOMATICS [J].
KLEIN, MR ;
VANBAALEN, CA ;
HOLWERDA, AM ;
KERKHOFGARDE, SR ;
BENDE, RJ ;
KEET, IPM ;
EEFTINCKSCHATTENKERK, JKM ;
OSTERHAUS, ADME ;
SCHUITEMAKER, H ;
MIEDEMA, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) :1365-1372
[28]   TEMPORAL ASSOCIATION OF CELLULAR IMMUNE-RESPONSES WITH THE INITIAL CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SYNDROME [J].
KOUP, RA ;
SAFRIT, JT ;
CAO, YZ ;
ANDREWS, CA ;
MCLEOD, G ;
BORKOWSKY, W ;
FARTHING, C ;
HO, DD .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4650-4655
[29]   The duration of antigenic stimulation determines the fate of naive and effector T cells [J].
Lezzi, G ;
Karjalainen, K ;
Lanzavecchia, A .
IMMUNITY, 1998, 8 (01) :89-95
[30]   EPSTEIN-BARR-VIRUS IN AIDS-RELATED PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA [J].
MACMAHON, EME ;
GLASS, JD ;
HAYWARD, SD ;
MANN, RB ;
BECKER, PS ;
CHARACHE, P ;
MCARTHUR, JC ;
AMBINDER, RF .
LANCET, 1991, 338 (8773) :969-973